Promote a Clinical Trial


Control of Myopia Using Novel Spectacle Lens Designs

Randomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical trial of 36-month duration to evaluate the safety and efficacy of a novel spectacle lens design in reducing the progression of juvenile myopia.

Sponsored by: SightGlass Vision, Inc.